A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures

Is this Study for You?

Let's Get Started!


Child to Adult

Type of Study



Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Nitish Harid,  MD

Nitish Harid, MD

Study ID

Protocol Number: 23-0395

More information available at ClinicalTrials.gov: NCT05614063

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers